Nuformix PLC – London-based pharmaceutical development company focused on fibrosis and oncology via drug repurposing – Hires Tim Metcalfe to be non-executive chair, starting September 1, Tuesday next week. Metcalfe is a corporate financier who among other City roles was joint CEO of Zeus Capital Ltd. At Nuformix, he replaces Julian Gilbert, who is stepping down for “personal reasons”. Gilbert has been on the board since 2020 and chair since 2022.
Current stock price: 0.17 pence, up 1.1% on Tuesday afternoon in London
12-month change: up from 0.070p
Copyright 2026 Alliance News Ltd. All Rights Reserved.
Source link
Author
- Ytv Market News
- Share-market news writer and analyst with deep experience covering equities, commodities, forex, and cryptocurrencies for readers in the USA, UK, Canada, and Australia. Ytv Market News delivers timely market updates, practical trading insights, and clear explanations of macro and company-level catalysts that move prices. Combines on-the-ground financial reporting with technical analysis, using concise charts and actionable ideas to help investors and traders make smarter decisions.
Latest entries
Crypto NewsAugust 25, 2026Arthur Hayes Predicts More Dollar Liquidity that Could Push Bitcoin’s Rally Further
Commodities NewsAugust 25, 2026TotalEnergies Moves Discounted Oil Through Hormuz as CEO Eyes Alternative Export Routes
Commodities NewsAugust 25, 2026PetroAmir Holds Output at 973 bbl/d, GANOPE Backs PetroSafwa
UsaAugust 25, 2026Mark Zuckerberg Says Personal AI Will Be the Future. Here Are 2 Stocks That Could Benefit
